Definitive Contract 75F40121C00076

Award Date 8/30/21
Potential Completion Date 3/5/24
Potential Value $3.9M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Arlington, VA 22201, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a $3,920,678.40 firm-fixed-price definitive contract awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to International Consulting Associates, Inc. (ICA), an SBA-certified 8(a), minority-owned, small disadvantaged business. The contract is for the development of a medical device predictive analytics tool to support the FDA's regulatory decision-making processes.

The contract is an 8(a) sole source award, which means it was set aside for eligible 8(a) program participants. ICA has an extensive track record of delivering a wide range of healthcare-related solutions, including predictive analytics tools, medical device evaluation models, and AI-enabled regulatory decision support, to federal health agencies like the Department of Health and Human Services (HHS) and its operating divisions. This contract highlights ICA's specialized expertise in areas such as healthcare data analytics, medical device safety, real-world evidence evaluation, and emerging technologies.

Generated 9/10/24, 10:05 AM